Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools

RMD Open

Volumn 2, Issue 2, 2016, Pages

  Van Riel, Piet ^a,b   Alten, Rieke ^c   Combe, Bernard ^d   Abdulganieva, Diana ^e   Bousquet, Paola ^f   Courtenay, Molly ^g   Curiale, Cinzia ^f   Gómez Centeno, Antonio ^h   Haugeberg, Glenn ⁱ   Leeb, Burkhard ^j,k,l   Puolakka, Kari ^m   Ravelli, Angelo ⁿ   Rintelen, Bernhard ^j,k   Sarzi Puttini, Piercarlo ^o  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Rheumatology ^*  (Netherlands)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIV MONTPELLIER   (France)

^e KAZAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^f PFIZER INC   (United States)

^g CARDIFF UNIVERSITY   (United Kingdom)

^h Parc Tauli Universitary Hospital   (Spain)

ⁱ MARTINA HANSENS HOSPITAL   (Norway)

^j Center for Rheumatology Lower Austria   (Austria)

^k Karl Landsteiner Institute for Clinical Rheumatology   (Austria)

^l MEDICAL UNIVERSITY OF GRAZ   (Austria)

^m SOUTH KARELIA CENTRAL HOSPITAL   (Finland)

ⁿ UNIVERSITY OF GENOA   (Italy)

^o UNIVERSITY OF MILAN   (Italy)

more..

Author keywords

Disease Activity; Patient perspective; Rheumatoid Arthritis

Indexed keywords

EID: 84999133351     PISSN: None     EISSN: 20565933     Source Type: Journal    
DOI: 10.1136/rmdopen-2016-000302     Document Type: Review

References (37)

1. Smolen JS, Breedveld FC, Burmester GR, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 2016;75:3-15.
2. Smolen JS, Braun J, Dougados M, et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis 2014;73:6-16.
3. Smolen JS, Landewé R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 2014;73:492-509.
4. Vermeer M, Kuper HH, Hoekstra M, et al. Implementation of a treat-To-Target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring Remission Induction Cohort Study. Arth Rheum 2011;63:2865-72.
5. Grigor C, Capell H, Stirling A, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): A single-blind randomised controlled trial. Lancet 2004;364:263-9.
6. Verstappen SM, Jacobs JW, van der Veen MJ, et al. Intensive treatment with methotrexate in early rheumatoid arthritis: Aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 2007;66:1443-9.
7. Coates LC, Moverley AR, McParland L, et al. Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): A UK multicentre, open-label, randomised controlled trial. Lancet 2015;386:2489-98.
8. Alemao E, Joo S, Kawabata H, et al. Effects of achieving target measures in RA on functional status, quality of life and resource utilization: Analysis of clinical practice data. Arthritis Care Res (Hoboken) 2016;68:308-17.
9. Haugeberg G, Hansen IJ, Soldal DM, et al. Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway. Arthritis Res Ther 2015;17:219.
10. Anderson J, Caplan L, Yazdany J, et al. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken) 2012;64:640-7.
11. Leeb BF, Andel I, Leder S, et al. The patients perspective and disease activity indexes. Rheumatology (Oxford) 2005;44:360-5.
12. Tillett W, Eder L, Goel N, et al. Enhanced Patient Involvement and the Need to Revise the Core Set-report from the Psoriatic Arthritis Working Group at OMERACT 2014. J Rheumatol 2015;42:2198-203.
13. Bykerk VP, Lie E, Bartlett SJ, et al. Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop. J Rheumatol 2014;41:799-809.
14. Singh JA, Saag KG, Bridges SL Jr, et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arth Rheumatol 2016;68:1-26.
15. Food and Drug Administration. Guidance for Industry. Patient-reported outcome measures: use in medical product development to support labeling claims. US FDA, 2009.
16. Peláez-Ballestas I. Patient reported outcome measures: what is their importance? Reumatol Clin 2012;8:105-6.
17. Pincus T, Strand V, Koch G, et al. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial. Arthritis Rheum 2003;48:625-30.
18. Rintelen B, Sautner J, Haindl P, et al. Remission in rheumatoid arthritis: A comparison of the 2 newly proposed ACR/EULAR remission criteria with the rheumatoid arthritis disease activity index-5, a patient self-report disease activity index. J Rheumatol 2013;40:394-400.
19. McManus RJ, Mant J, Haque MS, et al. Effect of self-monitoring and medication self-Titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: The TASMIN-SR randomized clinical trial. JAMA 2014;312:799-808.
20. Wicks P, Stamford J, Grootenhuis MA, et al. Innovations in e-health. Qual Life Res 2014;23:195-203.
21. Puchner R, Brezinschek HP, Fritz J, et al. Is the state of health of rheumatoid arthritis patients receiving adequate treatment, predictable?-results of a survey. BMC Musculoskelet Disord 2015;16:109.
22. Welsing PMJ, Landewe RBM, van Riel PLCM, et al. The Relationship between disease activity and radiologic progression in patients with rheumatoid arthritis. Arth Rheum 2004;50;2082-93.
23. Sargious A, Lee SJ. Remote collection of questionnaires. Clin Exp Rheumatol 2014;32(Suppl 85):S168-72.
24. Stevenson FA, Cox K, Britten N, et al. A systematic review of the research on communication between patients and healthcare professionals about medicines: The consequences for concordance. Health Expect 2004;7:235-45.
25. Mueller R, Walker U, Kyburz D, et al. Patients self-monitoring via smartphone: The Compass study correlation between patient self-Assessment of rheumatoid arthritis disease activity via smartphone technology and physicians validated scores. Arthritis Rheum 2014;66(Suppl 10):S1298. [abstract 2971].
26. Sikorska-Siudek K, Przygodzka M, Bojanowski S, et al. Mobile application for patients with rheumatoid arthritis (RA) as a supporting tool for disease activity monitoring: its usability and interoperability. Ann Rheum Dis 2015;74(Suppl 2):986. [abstract AB0280].
27. Mlekusch W. [Perspectives of mobile communication in the management of diabetics]. Wien Med Wochenschr 2011;161: 359-60.
28. Langer A, Langer H. Computer-Aided self-monitoring of disease activity in chronic arthritis: A new tool for disease management? Presented at EULAR 2004 [abstract HP0016]. http://www. abstracts2view.com/eular/view.php?nu=EULAR04L1-2004HP0016
29. De Ruvo E, Gargaro A, Sciarra L, et al. Early detection of adverse events with daily remote monitoring versus quarterly standard follow-up program in patients with CRT-D. Pacing Clin Electrophysiol 2011;34:208-16.
30. Aikens JE, Rosland AM, Piette JD. Improvements in illness self-management and psychological distress associated with telemonitoring support for adults with diabetes. Prim Care Diabetes 2015;9:127-34.
31. Ralston JD, Cook AJ, Anderson ML, et al. Home blood pressure monitoring, secure electronic messaging and medication intensification for improving hypertension control. Appl Clin Inform 2014;5:232-48.
32. Richter JG, Becker A, Koch T, et al. Self-Assessments of patients via Tablet PC in routine patient care: comparison with standardised paper questionnaires. Ann Rheum Dis 2008;67:1739-41.
33. Parekh SG, Nazarian DG, Lim CK. Adoption of information technology by resident physicians. Clin Orthop Relat Res 2004;421:107-11.
34. Michelsen B, Fiane R, Diamantopoulos AP, et al. A comparison of disease burden in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis. PLoS ONE 2015;10:e0123582.
35. Sokka T, Haugeberg G, Asikainen J, et al. Similar clinical outcomes in rheumatoid arthritis with more versus less expensive treatment strategies. Observational data from two rheumatology clinics. Clin Exp Rheumatol 2013;31:409-14.
36. Rødevand E, Haavardsholm E, Bader L, et al. The Norwegian BIORHEUMA project-Achieving patient benchmarking and patient register in one work flow using the GoTreatIt computer software system. Ann Rheum Dis 2012;71(Suppl 3):455. [abstract FRI0419].
37. Hendrikx J, Fransen J, Toniolo A, et al. Moving towards personalized healthcare: A patient reported outcome based algorithm can aid rheumatologists and patients in monitoring rheumatoid arthritis in daily clinical practice. Presented at ACR 2013 [abstract 2663]. http://acrabstracts.org/abstract/moving-Towardspersonalized-healthcare-A-patient-reported-outcome-basedalgorithm-can-Aid-rheumatologists-And-patients-in-monitoringrheumatoid-Arthritis-in-daily-clinical-practice/